Literature DB >> 17382110

Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis.

Barbara B Warner1, Ann Ladd Ryan, Kimberly Seeger, Anthony C Leonard, Christopher R Erwin, Brad W Warner.   

Abstract

OBJECTIVE: To examine the ontogeny of salivary epidermal growth factor (sEGF) in premature infants and to determine the relation of sEGF to the development of necrotizing enterocolitis (NEC). STUDY
DESIGN: Salivary EGF was prospectively measured in 327 infants with gestational ages from 23 weeks to term. Infants of < or = 32 weeks' gestation (n = 261) were followed with weekly sEGF measurements through 3 weeks of life. Multivariable regression analyses were used to determine variables significantly related to sEGF levels and to identify predictors of NEC.
RESULTS: Over the first 3 weeks of life, sEGF increased across gestational age and postnatal age categories. In multivariable models, gestational age was a significant predictor of sEGF levels (P < .009). In a cohort of 27 infants who had NEC, gestational age, race, and changes in sEGF levels between weeks of life 1 and 2 were predictive of the development of NEC. These infants had lower sEGF at week 1 and greater increases from week 1 to week 2 compared with infants without NEC.
CONCLUSIONS: There is a positive relation between sEGF levels and gestational age. Patterns of sEGF levels over the first 2 weeks of life were significantly related to development of NEC in very low birth weight infants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382110     DOI: 10.1016/j.jpeds.2006.11.059

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  20 in total

1.  Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis.

Authors:  Andrew A Maynard; Katerina Dvorak; Ludmila Khailova; Holly Dobrenen; Kelly M Arganbright; Melissa D Halpern; Ashish R Kurundkar; Akhil Maheshwari; Bohuslav Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-10       Impact factor: 4.052

Review 2.  Necrotizing enterocolitis in newborns: pathogenesis, prevention and management.

Authors:  Alecia M Thompson; Matthew J Bizzarro
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  New insights into necrotizing enterocolitis: From laboratory observation to personalized prevention and treatment.

Authors:  David J Hackam; Chhinder P Sodhi; Misty Good
Journal:  J Pediatr Surg       Date:  2018-06-18       Impact factor: 2.545

4.  Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants.

Authors:  Ardythe L Morrow; Jareen Meinzen-Derr; Pengwei Huang; Kurt R Schibler; Tanya Cahill; Mehdi Keddache; Suhas G Kallapur; David S Newburg; Meredith Tabangin; Barbara B Warner; Xi Jiang
Journal:  J Pediatr       Date:  2011-01-22       Impact factor: 4.406

5.  Acylcarnitine Profiles Reflect Metabolic Vulnerability for Necrotizing Enterocolitis in Newborns Born Premature.

Authors:  Karl G Sylvester; Zachary J Kastenberg; R Larry Moss; Gregory M Enns; Tina M Cowan; Gary M Shaw; David K Stevenson; Tiffany J Sinclair; Curt Scharfe; Kelli K Ryckman; Laura L Jelliffe-Pawlowski
Journal:  J Pediatr       Date:  2016-11-08       Impact factor: 4.406

Review 6.  Cytokines and growth factors in the developing intestine and during necrotizing enterocolitis.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Thao T B Ho; Benjamin A Torres; Robin K Ohls; Akhil Maheshwari
Journal:  Semin Perinatol       Date:  2016-11-07       Impact factor: 3.300

Review 7.  Pathogenesis of NEC: Role of the innate and adaptive immune response.

Authors:  Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning
Journal:  Semin Perinatol       Date:  2016-12-09       Impact factor: 3.300

Review 8.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

9.  Changes in hepatic cell junctions structure during experimental necrotizing enterocolitis: effect of EGF treatment.

Authors:  Ludmila Khailova; Katerina Dvorak; Kelly M Arganbright; Catherine S Williams; Melissa D Halpern; Bohuslav Dvorak
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

10.  Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis.

Authors:  Andrei Radulescu; Nicholas A Zorko; Xiaoyi Yu; Gail E Besner
Journal:  Pediatr Res       Date:  2009-04       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.